Source: Teva’s massive agreement to buy Allergan’s generics business continues to ripple its way through the industry. Australia’s Mayne Pharma has scooped up 42 products from the two companies, which are intent on winning antitrust clearance for their $40.5 billion deal. Though smaller in size, Mayne's $652 million buy is…...